✦ LIBER ✦

183 An Italian Cost-effectiveness Analysis of Paclitaxel Albumin (nab Paclitaxel) Vs Solvent-based Paclitaxel for Metastatic Breast Cancer Patients – the CONSTANZA Study

✍ Scribed by C. Lazzaro; R. Bordonaro; F. Cognetti; A. Fabi; S. De Placido; G. Arpino; P. Marchetti; A. Botticelli; P. Pronzato; E. Martelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN92 The Cost-Effectiveness of Nanopart

✍ Vandewalle, B.; Almeida, J.; Félix, J.; Silva, M.J.; Luz, R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Retrospective analysis of patients with

✍ T. Camburn; S. Tjulandin; N. Davidson; J. O'Shaughnessy; P. Bhar; W. Gradishar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

PCN96 A UK COST-UTILITY ANALYSIS OF PACL

✍ EJ McLeod; A Lloyd; Y Samyshkin; F Prunièras; P Canney 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

255 A Spanish Cost-utility Analysis of N

✍ E. Alba; E. Ciruelos; R. Lopez; J.M. López Vega; A. Lluch; M. Martín; P. Sánchez 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PCN77 Cost Effectiveness Analysis in the

✍ P.R. Maran; A. Aiello; M.R. Magrì; C. Alberti; E. Visentin; F. Venturini; G. Scr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

A cost-effectiveness analysis of Hercept

✍ A. Ratcliffe; C. Poole; D. Miles 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB